Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document-Reference-Cited by-同舟云学术

Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document

Published:2020-07 Issue: Volume:148 Page:157-166
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Lievens Yolande,Guckenberger Matthias^ORCID,Gomez Daniel,Hoyer Morten^ORCID,Iyengar Puneeth,Kindts Isabelle,Méndez Romero Alejandra,Nevens Daan,Palma David,Park Catherine,Ricardi Umberto^ORCID,Scorsetti Marta,Yu James,Woodward Wendy A.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference117 articles.

1. A 10-year single-center experience on 708 lung metastasectomies: the evidence of the “international registry of lung metastases”;Casiraghi;J Thorac Oncol,2011

2. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases;Fong;Ann Surg,1999

3. Outcomes after resection of synchronous or metachronous hepatic and pulmonary colorectal metastases;Miller;J Am Coll Surg,2007

4. Stereotactic body radiotherapy for oligometastases;Tree;Lancet Oncol,2013

5. Definition of synchronous oligo-metastatic non-small cell lung cancer – a consensus report;Dingemans;J Thorac Oncol,2019

Cited by 422 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma;Journal of Clinical and Experimental Hepatology;2025-01

2. OligoM-Cancer: A multidimensional information platform for deep phenotyping of heterogenous oligometastatic cancer;Computational and Structural Biotechnology Journal;2024-12

3. Stereotactic ablative radiotherapy for oligoprogressive solid tumours: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-11

4. Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions;Cancer Letters;2024-11

5. Patterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease after first-line chemotherapy: An ad hoc subgroup analysis of PRIMA/ENGOT-OV26/GOG-3012;Gynecologic Oncology;2024-10